Improvements in bloating, constipation patterns , and overall digestive comfort may correlate with broader immune function changes, though this connection has not been formally studied in clinical trials
It requires evidence of systematic review manipulation
If there are any abnormalities, the eye doctor will rule out other conditions and may conduct an imaging scan, like a CT or MRI, though those typically arent required to diagnose NAION
The findings are based on the SURPASS-6 randomized clinical trial sponosred by Eli Lilly, the makers of Mounjaro
The FDA has approved semaglutide for treating Type 2 diabetes and obesity
GLP1RAs have shown the ability to decrease the development and advancement of atherosclerosis in preclinical and clinical investigations [25, 26]